Dow Inc. 2024 Q3 10-Q Filing Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024, for Dow Inc. and its wholly-owned subsidiary, The Dow Chemical Company (TDCC). Dow is a global materials science company operating through three primary segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. The filing is a combined report due to the parent/subsidiary relationship.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Net Sales | $10,879 million | $10,730 million | $32,559 million | $34,001 million |
| Net Income (Dow Inc.) | $214 million | $302 million | $1,169 million | $694 million |
| Diluted EPS | $0.30 | $0.42 | $1.65 | $0.97 |
| Operating EBIT | $641 million | $626 million | $2,134 million | $2,219 million |
| Operating Cash Flow (Continuing) | $800 million (Q3 est.) | $1,658 million (Q3 est.) | $2,092 million | $3,536 million |
| Capital Expenditures | $736 million | $597 million | $2,173 million | $1,598 million |
| Free Cash Flow (9M) | ($81 million) | $1,938 million | — | — |
| Cash & Equivalents | $2,883 million | $3,080 million | — | — |
| Total Debt (Gross) | $16,571 million | $15,086 million | — | — |
| Net Debt | $13,327 million | $10,799 million | — | — |
Material Changes vs. Prior Period
- Revenue: Q3 net sales increased 1% year-over-year, driven by a 1% volume increase and flat local prices. However, the first nine months saw a 4% sales decline due to a 5% drop in local prices, partially offset by a 1% volume increase.
- Profitability: Q3 Net Income decreased 29% to $214 million compared to $302 million in Q3 2023. Conversely, 9M Net Income increased 68% to $1.169 billion, significantly aided by a lower effective tax rate (10.5% vs. 25.1% in 2023) due to a $194 million tax credit.
- Segment Performance:
- Packaging & Specialty Plastics: Q3 Operating EBIT rose 30% to $618 million due to lower raw material costs and higher selling prices.
- Industrial Intermediates & Infrastructure: Q3 Operating EBIT turned negative at ($53) million, down from $21 million, due to higher maintenance costs and lower margins.
- Performance Materials & Coatings: Q3 Operating EBIT declined 22% to $140 million due to higher raw material costs despite improved demand.
- Restructuring: The company recorded $24 million in restructuring and asset-related charges in Q3 2024, compared to zero in Q3 2023. This includes asset write-downs for polyurethanes and silicones assets.
- Significant Items: A $75 million pretax charge was recorded in Q3 related to an arbitration settlement for historical product claims from a divested business.
Guidance, Outlook, and Risks
- Outlook: Management expects to deliver more than $3 billion in underlying earnings by 2030 from counter-cyclical growth investments. Full-year 2024 capital spending is expected to be approximately $3 billion, driven by the Fort Saskatchewan Path2Zero project.
- Dividends & Buybacks: The Board declared a quarterly dividend of $0.70 per share. In Q3, the company repurchased $94 million of common stock, with approximately $931 million remaining under the $3 billion authorization.
- Strategic Actions:
- Acquired Circulus Holdings (plastic recycler) for ~$130 million in August 2024.
- Announced a sale of the flexible packaging laminating adhesives business to Arkema for ~$150 million (expected close end of 2024).
- Initiated a strategic review of select assets in Europe (polyurethanes) to optimize the global footprint.
- Risks & Contingencies:
- Legal: Ongoing asbestos-related litigation (Union Carbide) with a liability of $807 million; groundwater contamination matters with a liability of $158 million.
- Joint Ventures: Negative investment balance in Sadara Chemical Company ($420 million) due to challenging macroeconomic conditions.
- Market: Exposure to fluctuations in energy and raw material prices, currency exchange rates, and global economic conditions.
Investor Verification Checklist
- Tax Rate Volatility: Verify the sustainability of the 10.5% effective tax rate for the first nine months, which was heavily influenced by a one-time $194 million tax credit.
- Free Cash Flow: Note the negative Free Cash Flow of ($81) million for the first nine months, driven by high capital expenditures ($2.17 billion) exceeding operating cash flow.
- Asset Impairments: Monitor the impact of the announced strategic review of European assets and the ongoing restructuring program on future earnings.
- Joint Venture Exposure: Assess the financial impact of the negative equity balance in Sadara Chemical Company and its potential effect on future earnings.
- Debt Maturities: Confirm the company's ability to manage debt maturities, noting no substantive long-term debt maturities until 2027, but with a net debt increase to $13.3 billion.